Personalising medicine and the panel’s predictions for oncotechnologies (2/4)

Share :
Published: 11 Apr 2011
Views: 5408
Michael Baumann - ECCO President & Congress Chair; Jean Charles Soria - Scientific Co-Chair (ESMO); Peter Naredi - Surgery Vice Chair

In the era of personalised medicine, one major goal behind the multidisciplinary structure and multi-professional format of the Congress is to accelerate and advance tailored cancer therapy and care. Central to the discussions in Stockholm will be the exploration of current challenges, differing perspectives, approaches and contra-opinions to help anticipate the future of personalised medicine in oncology. The panel also discusses the promise of emerging technologies such as novel radiation technologies and image guided cancer therapies which will be presented and debated throughout the newly introduced Onco-Technology Track.